The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers

The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).

Automated summary

This paper discusses the increasing prevalence of multiple sclerosis among young people in developing countries and introduces the main biomarkers identified through Optical Coherence Tomography Angiography. It investigates the potential role of this technology in studying changes to the central nervous system.